• For the first time, this initiative launched by CEMEX and Tec de Monterrey University will receive proposals from all over the world • Over the past seven years, the Award has benefited more than 22,500 people in Mexico and the rest of Latin America MONTERREY, Mexico-Saturday, February 3rd 2018 [ AETOS Wire ] (BUSINESS WIRE) -- The CEMEX-Tec Center for Sustainable Development launched its call for the CEMEX-Tec Award 2018, which, for the first time in eight years, will receive projects not only from Mexico and the rest of Latin America, but also from all over the world. In its 8th edition, the CEMEX-Tec Award annually recognizes entrepreneurs and students who develop high-impact proposals and projects regarding sustainable development, innovation, and entrepreneurship. This award offers funding, specialized workshops, and networking opportunities. The CEMEX-Tec Award is divided into two categories with a global scope: Transforming Communities, aimed at undergraduate and graduat ... Read more »

• Showcasing FINEOS AdminSuite, the only cloud-based core administration solution designed specifically for group, voluntary and individual insurance DUBLIN-Thursday, February 1st 2018 [ AETOS Wire ] (BUSINESS WIRE) -- FINEOS Corporation, the market leading provider of core systems for Life, Accident and Health insurance, today announced it will be premier sponsor of the 2018 LIMRA Enrollment Technology Strategy Seminar in Jacksonville, Florida from February 6-8. The seminar provides a forum for LIMRA member insurance companies and technology service providers to participate in open discussion on how to cohesively work together and define better outcomes. The theme for this year’s conference is “Exploring Opportunities Together”. During the conference, FINEOS will demonstrate FINEOS AdminSuite, a cloud-based core administration solution designed specifically for group, voluntary and individual insurance. FINEOS is also the sponsor for the Hot Topics Roundtable discussion event ... Read more »

Milestone in advancing Urban Air Mobility achieved as Vahana celebrates two years since launch PENDLETON, Ore.-Friday, February 2nd 2018 [ AETOS Wire ] (BUSINESS WIRE)-- Vahana, the all electric, self-piloted, VTOL aircraft from A³ by Airbus, today announced the successful completion of its first full-scale flight test, reaching a height of 5 meters (16 feet) before descending safely. The test was completed at 8:52AM Pacific on January 31, 2018 at the Pendleton UAS Range in Pendleton, Oregon. Its first flight, with a duration of 53 seconds, was fully self-piloted and the vehicle completed a second flight the following day. “Today we are celebrating a great accomplishment in aerospace innovation,” said Zach Lovering, Project Executive of Vahana. “In just under two years, Vahana took a concept sketch on a napkin and built a full-scale, self-piloted aircraft that has successfully completed its first flight. Our team is grateful for the support we’ve received from A³ and the extended A ... Read more »

Dubaï, Émirats Arabes Unis-Lundi 5 Février 2018 [ AETOS Wire ] L’Arabia CSR Network annonce l’ouverture des candidatures aux organisations des secteurs public et privé pour participer au 11ème cycle des prix convoités de Arab CSR Awards. La cérémonie de remise des Prix aura lieu le 3 octobre 2018. L’Arabia CSR Network a ajouté qu'il s'agit d'une plateforme unique pour l'application des concepts de la Responsabilité Sociétale des Entreprises (RSE) dans la région arabe, où elle est perçue comme un véritable outil de construction et d'évaluation des connaissances. Le prix intègre les principes et les structures de certains des principaux cadres et normes de développement durable au monde, notamment le Pacte mondial des Nations Unies, la Global Reporting Initiative (GRI) et le modèle d'excellence EFQM. Les candidatures sont conçues de manière innovante avec une disposition d'auto-évaluation, des énoncés élaborés, un argumentaire et un soutien par des directives détaillées et des termes ... Read more »

DAEJEON, South Korea-Friday, February 2nd 2018 [ AETOS Wire ] (BUSINESS WIRE) -- PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announces it has entered into a collaborative agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA), through a subsidiary, to evaluate PharmAbcine’s anti-VEGFR2 mAb, TTAC-0001, in combination with MSD’s anti-PD-1 (programmed death receptor-1) therapy, KEYTRUDA® (pembrolizumab), in patients with recurrent glioblastoma multiforme (rGBM) and metastatic triple-negative breast cancer (TNBC). PharmAbcine’s lead candidate TTAC-0001, an investigational therapy, is a highly selective and potent anti-VEGFR2 (KDR/flk-1) mAb in clinical development for rGBM indications. VEGFR2 is over-expressed in most malignant tumors, such as gastric, liver, non-small cell lung cancer (NSCLC), ovarian, brain, colorectal, and breast cancers and this signaling pathway is a key regulator for ... Read more »